Severity of acute phase reaction in children receiving the first dose of zoledronic acid and the impact of the underlying condition: a cross-sectional studySapna Nayak, Lauren Rayner, Zulf Mughal, Georgia McKinney, Avril Mason, Sze Choong Wong, Raja Padidela, Amish Chinoy
31 May 2024
Pharmacokinetic and pharmacodynamic data from the NEOLEV1 and NEOLEV2 studiesCynthia Sharpe, Derek Z Yang, Richard H Haas, Gail E Reiner, Lilly Lee, Edmund V Capparelli, , NEOLEV2 Investigators, Suzanne L. Davis, Mark Nespeca, Jeffrey J. Gold, Maynard Rasmussen, Rachel Kuperman, Mary Jo Harbert, David MichelsonSee the full list of authors
20 June 2024
Medication errors involving intravenous paracetamol in children: experience from enquiries to the National Poisons Information ServiceFlorence Vincent, John Thompson, Laurence Gray, Sally Bradberry, Euan Sandilands, Ruben Thanacoody, David Tuthill
17 January 2024
Information in summaries of product characteristics about use in children is limited and needs standardisation: a systematic analysis in SwitzerlandRomy Tilen, Christoph Berger, Samuel Allemann, Henriette Meyer zu Schwabedissen
6 March 2024
Evaluation of age-banded dosing of oral paracetamol in hospitalised children: a retrospective analysis using clinical data in a tertiary paediatric hospitalKirstie Wright, Jennie Craske, Andrea Gill, John Jenson, Philip Arnold
25 April 2023
For children admitted to hospital, what interventions improve medication safety on ward rounds? A systematic reviewCharlotte King, Jan Dudley, Abigail Mee, Stephen Tomlin, Yincent Tse, Ashifa Trivedi, Daniel B Hawcutt,
15 February 2023
Technical response to the Neonatal and Paediatric Pharmacist Group’s proposal to standardise intravenous infusion concentrations for children in the UKJoseph Bulmer, Michael Drinnan, Jon Smith
23 February 2023
Identifying occlusions in paediatric intravenous infusion therapy and evaluating impact on systolic blood pressureJoseph Bulmer, Charlotte Robinson, Alison Bray, Michael Drinnan, Jan Hanot
3 February 2023
Optimising intravenous salbutamol in children: a phase 2 studySandra Walsh, Shan Pan, Yucheng Sheng, Frank Kloprogge, Joe F Standing, Brian J Anderson, Padmanabhan Ramnarayan, , OSTRICH Study Group, Mark Peters, David Inwald, Ami Parikh, Ian Maconochie, Mario Cortina-Borja
29 December 2022
Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infantsMiriam Pfiffner, Verena Gotta, Marc Pfister, Priska Vonbach, Eva Berger-Olah
13 September 2022